Partillion Bioscience Corp
Los Angeles, CA
- UEI
- WMNNPP5BWQM5
- CAGE
- 8KK41
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2360 Glendon Ave, Los Angeles, CA 90064, USA
- Website
- partillion.com
- Founded
- 2020
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Partillion Bioscience Corp
Partillion Bioscience Corp is a for-profit corporate entity located in Los Angeles, California, specializing in advanced biotechnology research and development, with a particular focus on hydrogel microparticle technology called "nanovials". The company develops innovative screening and selection technologies for biological research, with an emphasis on high-throughput approaches to analyzing and sorting single cells based on their secretion characteristics. Registered in SAM.gov since April 15, 2020, Partillion operates as a manufacturer of goods with expertise in developing sophisticated bioengineering solutions for research and therapeutic development.
The company has secured multiple federal grants primarily from the National Institute of General Medical Sciences and the National Institute of Allergy and Infectious Diseases, focusing on cutting-edge research in cell therapy, antibody discovery, and biomedical engineering. Their grant-funded projects have centered on developing advanced workflows utilizing their nanovial technology to enable ultra high-throughput screening of cells like B cells, CAR-T cells, and producer cell lines. Specific research areas include developing multiplexed single-cell secretion assays, creating methods for linking antibody sequences to functional properties, engineered cell therapy discovery, and innovative approaches to selecting and analyzing cells based on their secretion capabilities. The grants, ranging from approximately $255,916 to $1,000,000, support Phase I and Phase II Small Business Innovation Research (SBIR) projects aimed at improving biotechnological research methodologies and potentially accelerating therapeutic candidate development across various medical domains.
Quick answers
What is Partillion Bioscience Corp's UEI?
Partillion Bioscience Corp's Unique Entity ID (UEI) in SAM.gov is WMNNPP5BWQM5.
What is Partillion Bioscience Corp's CAGE code?
Partillion Bioscience Corp's CAGE code is 8KK41.
What is Partillion Bioscience Corp's primary NAICS code?
Partillion Bioscience Corp's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Partillion Bioscience Corp located?
Partillion Bioscience Corp's physical address in SAM.gov is 2360 Glendon Ave, Los Angeles, CA 90064, USA.
Is Partillion Bioscience Corp registered in SAM.gov?
Yes. Partillion Bioscience Corp's SAM.gov registration is active through February 26, 2027.
What is Partillion Bioscience Corp's most recent federal award?
Partillion Bioscience Corp's most recent federal grant award is Nanovial kits for large-scale cell-cell interaction sequencing - abstract therapeutic discovery increasingly depends… (R44GM165220), from National Institute of General Medical Sciences, on September 1, 2026.
On GovTribe
See Partillion Bioscience Corp's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors